Status:
RECRUITING
Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors
Lead Sponsor:
Leiden University Medical Center
Collaborating Sponsors:
Philips Healthcare
European Commission
Conditions:
Liver Cancer
Liver Metastases
Eligibility:
All Genders
18-110 years
Brief Summary
The endpoint of this study is to develop and validate algorithms, using artificial intelligence and machine learning, to optimize patient selection, treatment planning, treatment evaluation and outcom...
Detailed Description
This study is part of the IMAGIO (Imaging and advanced guidance for workflow optimization in interventional oncology) project. This project aims to leverage Interventional Oncology in the clinical set...
Eligibility Criteria
Inclusion
- 18 years or above
- Candidate for percutaneous thermal liver ablation as discussed in a multidisciplinary tumorboard (MDT)
- Informed consent
Exclusion
- Patients lacking capacity to give informed consent.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06179602
Start Date
January 1 2024
End Date
January 1 2028
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden University Medical Centre
Leiden, Netherlands